Participating in the 'Pass the Phone' challenge with antipsychotic medications offers a unique and memorable way to learn about these powerful drugs, their applications, and side effects. Each antipsychotic carries its own risk profile and therapeutic benefits, making understanding them crucial for healthcare professionals and students alike. For example, Haloperidol (Haldol) is renowned for its rapid control of agitation but comes with a risk of extrapyramidal symptoms (EPS) like dystonia, which requires careful monitoring. Olanzapine (Zyprexa), while effective for mood stabilization, is often associated with significant weight gain contributing to metabolic syndrome. Quetiapine (Seroquel) earns its nickname as versatile due to its use across depression, mania, anxiety, and sleep disorders but can cause sedation that some patients might misinterpret as restful self-care. Risperidone (Risperdal) effectively treats schizophrenia and bipolar disorder but can elevate prolactin levels, leading to hormonal side effects. Clozapine (Clozaril) remains the last-resort medication for treatment-resistant cases and requires intense surveillance of white blood cell counts to prevent agranulocytosis. Aripiprazole (Abilify), a partial dopamine agonist, offers a balanced approach to dopamine regulation, minimizing some side effects but with unique warnings for elderly patients. Ziprasidone (Geodon) carries the risk of QT prolongation and thus demands cardiac monitoring. Paliperidone (Invega), an extended-release form of Risperidone, offers improved compliance with monthly or quarterly dosing. Engaging with these antipsychotics through the challenge also emphasizes the importance of monitoring diverse parameters including EPS, metabolic effects, prolactin levels, white blood cells, and QT intervals. From my experience, recognizing side effects early and communicating them effectively with patients helps optimize treatment outcomes and adherence. The challenge underscores that despite their complexities and risks, these medications offer invaluable benefits for managing severe psychiatric disorders. Balancing efficacy with side effect management defines the art and science of psychopharmacology. Overall, this innovative educational approach makes learning these critical details more accessible and engaging while reinforcing the importance of comprehensive patient monitoring.